ArticleProceedings of the National Academy of Sciences of the United States of America2019

Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.

Susan Wyllie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.